Previously, gender-, age-, and APOE-adjusted logistic regression analysis revealed a protective effect for the C allele carriers of rs7120118 among a Finnish clinic-based AD-control cohort, indicating that these patients have a decreased risk for AD [18]. The gene discussed is APOE; the disease is Alzheimer disease.